nVerses Capital’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
nVerses Capital's CMPX Position: Q3 2026 in Review
nVerses Capital sold out of Compass Therapeutics (CMPX) in Q3 2026, closing a stake of 23,330 shares — an estimated $51.1K sold.
nVerses Capital first reported a position in CMPX in Q2 2026 and held it in 1 quarter. The position peaked at $51.1K in Q2 2026. 172 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.
- nVerses Capital reported no remaining Compass Therapeutics position as of Q3 2026 after selling out during the quarter.
- nVerses Capital sold 23,330 Compass Therapeutics shares in Q3 2026, an estimated $51.1K.
- nVerses Capital first reported a position in Compass Therapeutics in Q2 2026 and held it in 1 quarter.
- nVerses Capital's Compass Therapeutics position peaked at $51.1K in Q2 2026.
- 172 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.
Based on nVerses Capital's 13F filing for Q3 2026.